Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-04-30 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75010), Paris
PHARMACIE DE LA GARE DU NORD : revenue, balance sheet and financial ratios
PHARMACIE DE LA GARE DU NORD is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75010),
this company of category PME
shows in 2020 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA GARE DU NORD (SIREN 498233618)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue
N/C
N/C
N/C
N/C
2 253 266 €
1 264 863 €
N/C
2 817 848 €
2 721 159 €
2 036 645 €
2 451 628 €
2 500 896 €
2 639 119 €
Net income
475 300 €
288 729 €
810 158 €
402 869 €
127 531 €
115 126 €
302 902 €
292 093 €
265 257 €
65 198 €
160 528 €
194 824 €
168 306 €
EBITDA
N/C
N/C
N/C
N/C
347 904 €
148 247 €
N/C
361 259 €
340 516 €
146 286 €
248 720 €
267 212 €
261 550 €
Net margin
N/C
N/C
N/C
N/C
5.7%
9.1%
N/C
10.4%
9.7%
3.2%
6.5%
7.8%
6.4%
Revenue and income statement
In 2024, PHARMACIE DE LA GARE DU NORD generates positive net income of 475 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2012-2024: 168 k€ -> 475 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
475 300 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 130%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
129.645%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.884%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA GARE DU NORD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
435.72
425.353
469.039
609.906
375.357
353.594
368.488
388.145
425.371
263.93
132.472
186.381
129.645
Financial autonomy
15.653
16.777
15.455
11.886
17.523
17.668
18.681
18.87
17.372
23.923
36.769
31.129
35.884
Repayment capacity
11.905
11.103
13.166
32.029
8.039
7.112
None
18.258
21.415
None
None
None
None
Cash flow / Revenue
6.911%
7.829%
6.854%
3.681%
10.206%
10.958%
None%
9.88%
6.066%
None%
None%
None%
None%
Sector positioning
Debt ratio
129.652024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average+5 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA GARE DU NORD (129.65) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.88%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE DE LA GARE DU NORD (35.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 232.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
232.191
Liquidity indicators evolution PHARMACIE DE LA GARE DU NORD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
28.51
33.275
38.927
55.154
65.275
65.759
69.349
61.632
280.49
252.571
273.602
344.418
232.191
Interest coverage
29.478
26.442
32.046
48.631
17.225
14.355
None
15.131
3.99
None
None
None
None
Sector positioning
Liquidity ratio
232.192024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA GARE DU NORD (232.19) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA GARE DU NORD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
72 101 €
75 927 €
144 425 €
194 337 €
137 500 €
250 591 €
0 €
98 925 €
407 481 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
16
19
24
41
32
31
0
37
47
0
0
0
0
Customer payment term (days)
1
1
1
1
1
0
0
3
5
81
0
16
0
Supplier payment term (days)
71
58
63
102
79
106
0
74
43
540
0
0
0
Positioning of PHARMACIE DE LA GARE DU NORD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA GARE DU NORD is estimated at
6 635 539 €
(range 4 620 884€ - 9 927 146€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
4620k€6635k€9927k€
6 635 539 €Range: 4 620 884€ - 9 927 146€
NAF 5 année 2024
Valuation method used
Net Income Multiple
475 300 €
×
14.0x
=6 635 539 €
Range: 4 620 885€ - 9 927 147€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA GARE DU NORD with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA GARE DU NORD
What is the revenue of PHARMACIE DE LA GARE DU NORD ?
The revenue of PHARMACIE DE LA GARE DU NORD in 2020 is 2.3 M€.
Is PHARMACIE DE LA GARE DU NORD profitable?
Yes, PHARMACIE DE LA GARE DU NORD generated a net profit of 475 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA GARE DU NORD ?
The headquarters of PHARMACIE DE LA GARE DU NORD is located in PARIS (75010), in the department Paris.
Where to find the tax return of PHARMACIE DE LA GARE DU NORD ?
The tax return of PHARMACIE DE LA GARE DU NORD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA GARE DU NORD operate?
PHARMACIE DE LA GARE DU NORD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart